Efficient mobilization of haematopoietic progenitors after a single injection of pegylated recombinant human granulocyte colony-stimulating factor in mouse strains with distinct marrow-cell pool sizes

British Journal of Haematology

Volumn 110, Issue 3, 2000, Pages 638-646

  De Haan, Gerald ^a   Ausema, Albertina ^a   Wilkens, Marga ^a   Molineux, Graham ^b   Dontje, Bert ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b AMGEN INC   (United States)

Author keywords

G CSF; Mobilization; Pharmacogenetics; Stem cells

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SD 01; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOLOGICAL THERAPY; BONE MARROW CELL; CELL COUNT; CELL PROLIFERATION; CHROMOSOME 12; COLONY FORMING UNIT GM; CONTROLLED STUDY; DRUG EFFECT; DRUG FORMULATION; FEMALE; HEMATOPOIETIC STEM CELL; MOUSE; NONHUMAN; PHARMACOGENETICS; PHENOTYPE; PRIORITY JOURNAL; STEM CELL;

ACYLTRANSFERASES; ANIMALS; BONE MARROW CELLS; CELL DIVISION; COLONY-FORMING UNITS ASSAY; FEMALE; FILGRASTIM; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; INJECTIONS, SUBCUTANEOUS; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, INBRED STRAINS; PENICILLIN-BINDING PROTEINS; RECOMBINANT PROTEINS; SERINE PROTEINASE INHIBITORS; SPECIES SPECIFICITY;

EID: 0033772250     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02252.x     Document Type: Article

References (32)

1. Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): An analysis of factors correlating with the tempo of engraftment after transplantation
2. Relationship between molecular mass and duration of activity of polyethylene glycol conjugated granulocyte colony-stimulating factor mutein
3. Individual stem cell quality in leukapheresis products is related to the number of mobilized stem cells
4. Intrinsic and extrinsic control of hemopoietic stem cell numbers: Mapping of a stem cell gene
5. Mutual inhibition of murine erythropoiesis and granulopoiesis during combined erythropoietin, granulocyte colony-stimulating factor, and stem cell factor administration: In vivo interactions and dose-response surfaces
6. Peripheral blood progenitor cell (PBPC) counts during steady-state hematopoiesis allow to estimate the yield of mobilized PBPC after filgrastim (R-metHuG-CSF)-supported cytotoxic chemotherapy
7. Peripheral blood progenitor cell (PBPC) counts during steady-state haemopoiesis enable the estimation of the yield of mobilized PBPC after granulocyte colony-stimulating factor supported cytotoxic chemotherapy: An update on 100 patients
8. The minimum CD34 threshold depends on prior chemotherapy in autologous peripheral blood stem cell recipients
9. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma
10. Progenitor cell mobilization by granulocyte colony-stimulating factor controlled by loci on chromosomes 2 and 11
11. Why pharmacogenomics? Why now?
12. Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation
13. Predictive value of the steady-state peripheral blood progenitor cell (PBPC) counts for the yield of PBPC collected by leukapheresis after mobilization by granulocyte colony-stimulating factor (G-CSF) alone or chemotherapy and G-CSF
14. Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results
15. Cytokines increase human hemopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins
16. A Macintosh program for storage and analysis of experimental mapping data
17. The 'G-CSF test': The response to a single dose of granulocyte colony-stimulating factor predicts mobilization of hemopoietic progenitors in patients with hematologic malignancies
18. A comparison of hematopoiesis in normal and splenectomized mice treated with granulocyte colony-stimulating factor
19. A new form of Filgrastim with sustained duration in vivo and enhanced ability to mobilize PBSC in both mice and humans
20. VLA-4 and VCAM-1 are the principal adhesion molecules involved in the interaction between blast colony-forming cells and bone marrow stromal cells
21. The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen
22. Use of limiting-dilution type long-term marrow cultures in frequency analysis of marrow-repopulating and spleen colony-forming hematopoietic stem cells in the mouse
23. Peripheral blood progenitor cell collections in multiple myeloma: Predictors and management of inadequate collections
24. Do steady-state peripheral blood progenitor cell (PBPC) counts predict the yield of PBPC mobilized by filgrastim alone?
25. Broad inter-individual variations in circulating progenitor cell numbers induced by granulocyte colony-stimulating factor therapy
26. Genetic influences determining progenitor cell mobilization and leukocytosis induced by granulocyte colony-stimulating factor
27. The utilization of cytokines in stem cell mobilization strategies
28. Pharmacokinetics of recombinant human granulocyte colony-stimulating factor in the rat. Single and multiple dosing studies
29. Genotyping new BXD recombinant inbred mouse strains and comparison of BXD and consensus maps
30. A history of haemopoietic cell transplantation
31. Non-obese diabetic/severe combined immunodeficiency (NOD/SCID) mouse as a model system to study the engraftment and mobilization of human peripheral blood stem cells
32. Differential adherence of murine hematopoietic stem cell subsets to fibronectin